Reaction

Blood Thyroid Stimulating Hormone Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,492 reports · 87 co-occurring drugs

As of the last recalculation, Blood Thyroid Stimulating Hormone Decreased appears in 4,492 FAERS reports alongside 87 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 50.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alemtuzumab	200	50.1	50.6
Liothyronine Sodium	79	42.8	43.2
Thyroid, Porcine	61	26.9	27.0
Levothyroxine Sodium	1,281	26.0	26.1
Dimenhydrinate	57	25.1	25.2
Methimazole	32	19.0	19.1
Levothyroxine Sodium Anhydrous	219	10.6	10.6
Ipilimumab	94	10.3	10.3
Amiodarone Hydrochloride	17	7.1	7.1
Lithium	37	6.8	6.9
Lithium Bromatum	37	6.8	6.9
Octreotide Acetate	43	6.6	6.6
Pembrolizumab	138	6.2	6.2
Nivolumab	126	6.2	6.2
Methylprednisolone Sodium Succinate	61	6.2	6.2
Lithium Carbonate	22	6.0	6.0
Somatropin	93	6.0	6.0
Methylprednisolone	157	5.4	5.4
Pemetrexed	24	5.2	5.2
Testosterone	26	5.2	5.2
Doxepin Hydrochloride	13	4.8	4.8
Diphenhydramine Hcl	11	4.6	4.6
Durvalumab	20	4.6	4.6
Dronedarone	10	4.5	4.6
Biotin	30	4.5	4.5
Progesterone	22	4.5	4.5
Cimetidine	9	4.3	4.3
Hydrocortisone 1%	62	4.3	4.3
Anti-Itch	61	4.3	4.3
Anti-Pruritic	61	4.3	4.3
Antipruritic (Anti-Itch)	61	4.3	4.3
Cool Relief Gel With Aloe	61	4.3	4.3
Drs. Hydrocortisone	61	4.3	4.3
Hydrocortisone Continuous Spray	61	4.3	4.3
Hydrocortisone Spray	61	4.3	4.3
Anti-Itch Cream	61	4.3	4.3
Hydrocortisone Lotion	61	4.3	4.3
Hydrocortisone Cream 1%	61	4.3	4.3
Hydrocortisone Cream 1/2%	61	4.3	4.3
Hydrocortisone Cream	61	4.2	4.2
Pemetrexed Disodium	34	4.2	4.2
Testosterone Cypionate	8	4.2	4.2
Hydrocortisone Acetate	63	4.1	4.1
Abacavir Sulfate	8	3.8	3.8
Amantadine	12	3.6	3.6
Lanreotide Acetate	6	3.5	3.6
Valproic Acid	24	3.5	3.5
Fexofenadine Hcl	7	3.5	3.5
Nebivolol Hydrochloride	24	3.3	3.3
Propranolol Hydrochloride	50	3.2	3.2
Oxybutynin Chloride	6	3.2	3.2
Prochlorperazine Maleate	6	3.0	3.0
Quinapril Hydrochloride	5	2.9	2.9
Finasteride	36	2.8	2.8
Triamcinolone Acetonide Ointment Usp, 0.05%	14	2.8	2.8
Peginterferon Alfa-2A	32	2.8	2.8
Tizanidine	14	2.7	2.7
Multivitamin	29	2.7	2.7
Dofetilide	6	2.6	2.6
Estradiol	49	2.6	2.6
Lenvatinib	18	2.5	2.5
Atezolizumab	21	2.5	2.5
Carboxymethylcellulose Sodium	5	2.5	2.5
Carboplatin	67	2.5	2.5
Sunitinib Malate	20	2.4	2.4
Guanfacine	4	2.4	2.4
Encorafenib	5	2.3	2.3
Asfotase Alfa	5	2.3	2.3
Acetaminophen And Codeine	6	2.3	2.3
Pitavastatin Calcium	5	2.3	2.3
Iohexol	4	2.2	2.2
Dalfampridine	34	2.2	2.2
Teriflunomide	21	2.2	2.2
Cabozantinib	22	2.1	2.1
Ribavirin	29	2.1	2.1
Paclitaxel (Aibumin-Bound)	37	2.1	2.1
Acalabrutinib	5	1.9	1.9
Ranitidine	80	1.9	1.9
Paclitaxel	39	1.8	1.8
Rimegepant Sulfate	5	1.8	1.8
Axitinib	7	1.7	1.7
Conjugated Estrogens And Medroxyprogesterone Acetate	6	1.2	1.2
Lifitegrast	4	1.1	1.1
Abaloparatide	6	0.9	0.9
Tirzepatide	26	0.7	0.7
Erenumab-Aooe	8	0.7	0.7
Nirmatrelvir And Ritonavir	7	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.